When it comes to lateral flow diagnostics – especially STI testing – simplicity is everything. Tests must be intuitive to use and crystal clear to interpret – especially when regulatory bodies like the FDA have strict requirements around user age groups and instruction clarity.

But here’s the reality check: Not all CDMO partners are created equal.

The game-changer? Working with a reputable partner who truly understands regulatory landscapes AND considers the commercial viability of your product from day one.
Because what good is regulatory approval if your product can’t succeed in the market?

Find Out From Home Founder & CEO Yannick Namia gives insight into how the right partnership transforms diagnostic development from concept to commercial success.